Fundraising Fox

Evelo Biosciences

Cambridge, US · Founded 2014 · Delaware corporation · 16 employees on LinkedIn · 3 known investors

Biotech

Founders & leadership

JG
Jennifer GlennonExecutive
B(
Balkrishan (Simba) Gill, Ph.D.Executive
DM
Duncan McHaleExecutive
WD
William DeVaulExecutive
MB
Mark Bodmer, Ph.D.Executive

Board

NB
Noubar B. Afeyan, Ph.D.Board director
DR
David R. EpsteinBoard director
LA
Lord Ara DarziBoard director
DP
David P. PerryBoard director
TM
Theodose Melas-KyriaziBoard director

Investors · 3

SV Health InvestorsBoston · $1M – $20M
Flagship PioneeringreportedCambridge · $500K – $10M
Kaiser Permanente VenturesreportedSan Francisco · $2M – $5M

Reported raises · per SEC filings

Form D private placements

$131.5M disclosed across 2 rounds · 2017–2018

▶$81.5MraisedMar 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Noubar B. Afeyan, Ph.D.Director
  • Jennifer GlennonExecutive Officer
  • Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
  • David R. EpsteinDirector
  • Lord Ara DarziDirector
  • Duncan McHaleExecutive Officer
  • David P. PerryDirector
  • William DeVaulExecutive Officer
  • Mark Bodmer, Ph.D.Executive Officer
  • Theodose Melas-KyriaziDirector
Offering amount
$81.5M
Amount sold
$81.5M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedFeb 2018 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Balkrishan (Simba) Gill, Ph.D.Executive Officer, Director
  • David P. PerryDirector
  • David A. Berry, M.D., Ph.D.Director
  • Mark Bodmer, Ph.D.Executive Officer
  • William DeVaulExecutive Officer
  • Jennifer GlennonExecutive Officer
  • Theodose Melas-KyriaziDirector
  • Lord Ara DarziDirector
  • David R. EpsteinDirector
  • Duncan McHaleExecutive Officer
  • Noubar B. Afeyan, Ph.D.Director
Offering amount
$50M
Amount sold
$50M
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Evelo Biosciences went on to found or lead other companies.

Noubar AfeyanCo-Founder and ChairmanFounded ProFound Therapeutics +11Brian GoodmanCofounder, Head of Scientific StrategyFounded Aktis Oncology

In the news

Salestoolssalestools.io · Aug 2024Evelo Biosciences digests new funding - Global Venturingglobalventuring.com · Feb 2018Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Teamprnewswire.com · Jul 2017Evelo raises $50M to take monoclonal microbials into clinic | Fierce Biotechfiercebiotech.com · Jul 2017

Frequently asked questions

Who are Evelo Biosciences's investors?
Evelo Biosciences's investors include SV Health Investors, Flagship Pioneering, Kaiser Permanente Ventures.
How much funding has Evelo Biosciences raised?
Evelo Biosciences has disclosed $131.5M raised across 2 rounds.
Where is Evelo Biosciences headquartered?
Evelo Biosciences is headquartered in Cambridge, US.